Rafita Haque | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Rafita Haque | Cardiovascular Pharmacology | Best Researcher Award

PhD Student at Florida International University | United States

Ms. Rafita Haque is a dedicated PhD candidate in Computer and Electrical Engineering at Florida International University, USA. With a strong academic and research background in AI, biomedical sensors, and data security, she is passionate about advancing digital health solutions. Her teaching and research experiences span universities in Bangladesh and the U.S., with significant industry exposure in software quality assurance. She has authored several indexed publications, received international awards, and holds active research interests in cardiovascular health monitoring using signal analysis and intelligent systems. Ms. Haque’s career is a blend of academic excellence, innovative research, and practical engineering application.

Publication Profile 

Google Scholar

Orcid

Education 

Ms. Haque is pursuing a PhD in Computer and Electrical Engineering at Florida International University, Miami, with a research focus on AI, biomedical devices, and cardiovascular health management. She holds a Master’s degree in Software Engineering from Daffodil International University, where her thesis explored C2C information quality in Facebook-based purchase decisions. She completed her B.Sc. in Computer Science and Engineering from Gono Bishwabidyalay, focusing on network security systems. Her academic training reflects a strong foundation in data analysis, security, and AI-driven healthcare technologies, supported by hands-on research and multiple technical certifications in networking and development.

Experience 

Ms. Rafita Haque has rich academic and industry experience. She served as a lecturer in Software Engineering at Daffodil International University and in Computer Science at the Asian University of Bangladesh, teaching core computing and system design courses. She also worked as an SQA Engineer at Data-Soft Systems and Cloud Production Ltd., where she tested and improved AML solutions for the banking and insurance sectors. Her work involved ASP.NET, MySQL, Python, and NoSQL. She’s recognized for developing secure network systems and cloud-based tools, blending teaching excellence with real-world software and systems engineering experience.

Awards  

Ms. Rafita Haque has earned multiple academic and professional honors. She received the Best Paper Award (IoT Track) at the 1st International Conference on Technology Innovation and Data Sciences (ICTIDS) in Malaysia, 2019. She also won the Best Project Award at Gono Bishwabidyalay’s Project Fair (2015) for her secure network system. Additionally, she presented her research at the Blockchain Olympiad Bangladesh (BCOLBD) in 2020. Her outstanding academic track and publication record in Scopus and Springer-indexed journals, alongside her active participation in international conferences, underscore her contributions to technology, cybersecurity, and healthcare innovation.

Research Focus 

Ms. Haque’s research interests include Artificial Intelligence (AI), Biomedical Sensors, Photoplethysmogram (PPG) signal analysis, data security, and cardiovascular health management systems. Her work integrates machine learning with optical and biomedical systems to create intelligent diagnostic tools. She is particularly focused on AI-based monitoring of cardiovascular conditions, secured health data exchange using blockchain, and real-time signal analysis. Her multidisciplinary expertise bridges computer science with healthcare innovation, emphasizing secure, smart systems that support precision medicine. Through cutting-edge publications and collaborative research, she aims to advance smart biomedical technologies and secure healthcare data infrastructures globally.

Publication Top Notes

Broken authentication and session management vulnerability: a case study of web application
Journal: International Journal of Simulation Systems, Science & Technology
Cited by: 48
Year: 2018

Blockchain-based information security of electronic medical records (EMR) in a healthcare communication system
Cited by: 36
Year: 2021

Integration of blockchain and remote database access protocol-based database
Cited by: 14
Year: 2020

Modeling the role of C2C information quality on purchase decision in Facebook
Cited by: 13
Year: 2018

A cloud of things (CoT) approach for monitoring product purchase and price hike
Cited by: 10
Year: 2021

Identification of construction era for Indian subcontinent ancient and heritage buildings by using deep learning
Cited by: 10
Year: 2020

Performance Analysis of Different Feature Detection Techniques for Modern and Old Buildings
Cited by: 9
Year: 2018

A study of Ajax template injection in web applications
Cited by: 9
Year: 2018

A Combined Model of Blockchain, Price Intelligence and IoT for Reducing the Corruption and Poverty
Cited by: 8
Year: 2018

Digital Certificate Forgery Prevention Using Blockchain Technology
Year: 2023

Deep long short-term memory (LSTM) network for continuous blood pressure monitoring
Year: 2025
Cited by: 1

An Ensemble-Based AI Approach for Continuous Blood Pressure Estimation in Health Monitoring Applications
Journal: Sensors
Year: 2025

Conclusion

Ms. Rafita Haque is a promising early-career researcher with significant accomplishments in AI, biomedical applications, and information security. Her interdisciplinary focus, hands-on industry experience, academic excellence, and publication record collectively position her as a strong candidate for the Research for Best Researcher Award. With further engagement in high-impact, independently led projects and global research forums, she is poised to emerge as a future leader in her field.

Song Guo Zheng | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Song Guo Zheng | Drug Discovery and Development | Best Researcher Award

Chair Professor at Shanghai Jiao Tong University School of Medicine | China

Prof. Song Guo Zheng, M.D., Ph.D., is an internationally renowned immunologist and clinician-scientist specializing in rheumatology, molecular immunology, and translational medicine. He currently serves as Chair Professor and Dean of the School of Cell and Gene Therapy at Shanghai Jiao Tong University. With academic leadership roles across prestigious institutions in the U.S. and China, his pioneering work spans autoimmunity, cell therapy, and immunoregulation. A prolific author with over 110 peer-reviewed publications in top-tier journals, Prof. Zheng is also a highly decorated researcher and active leader in global immunology societies. His contributions continue to shape modern immunotherapy and precision medicine.

Publication Profile 

Google Scholar

Orcid

Education 

Prof. Zheng earned his Ph.D. in Molecular Immunology from the University of Orleans, France (2011), and a Master’s in Pathology and Immunology from Shanghai Medical University (1992). He completed his M.D. at Anhui Medical University (1984). His clinical training included a residency in surgery at Chizhou City Hospital (1984–1989) and an internship at Shanghai Zhabei Hospital (1983–1984). He further pursued a pathology fellowship at Shanghai Medical University Cancer Hospital (1989–1993). These academic and clinical foundations laid the groundwork for a distinguished career in immunology, clinical research, and translational medicine across both China and the United States.

Experience 

Prof. Zheng currently serves as Chair Professor at Shanghai Jiao Tong University and Dean of the School of Cell and Gene Therapy (2023–Present). He previously held senior positions including the Ronald L. Whisler Chair in Rheumatology and Immunology at Ohio State University (2018–2022) and Director at Penn State University’s College of Medicine (2013–2018). His U.S. academic journey began at the University of Southern California as an assistant and associate professor (2004–2013), after postdoctoral work at USC and UCLA. With leadership in research, teaching, and clinical science, he has become a global authority in immunological therapeutics and rheumatology.

Awards

Prof. Zheng has received numerous prestigious honors, including the Outstanding Scientist Award (2023, USA) and the Distinguished Clinical Immunologist Award (2019, China). He was awarded the Edmund L. Dubois Award (2019), NIH STAR Award (2016–2021), and was Chair of NIH MOSS Study Section (2016). Notably, he earned the James R. Klinenberg Award for best immunologist in Southern California (2007) and the Freda Newton Memorial Scholar Award (2006). He is an elected member of The Henry Kunkel Society (2012) and a recipient of the ACR Investigator Award (2008–2010), reflecting his impactful and sustained contributions to clinical immunology.

Research Focus 

Prof. Zheng’s research centers on molecular immunology, particularly in autoimmune diseases, Treg/Th17 cell modulation, and immune tolerance mechanisms. He investigates immunometabolism, gene and cell therapy, and inflammatory signaling pathways with an emphasis on clinical translation. His studies on cytokines, nanomedicine, and immune checkpoint regulation aim to advance precision therapeutics for rheumatic and inflammatory diseases. He integrates cutting-edge techniques including single-cell sequencing, CRISPR-based modulation, and nano-drug delivery systems. His innovative research is highly cited and supports next-generation treatments for autoimmunity, cancer immunotherapy, and organ-specific inflammation, shaping global trends in immune-based medical interventions.

Publication Top Notes

Natural and induced CD4+ CD25+ cells educate CD4+ CD25− cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10

IL-2 is essential for TGF-β to convert naive CD4+ CD25− cells to CD25+ Foxp3+ regulatory T cells and for expansion of these cells

Role of vitamin A in the immune system

Generation ex vivo of TGF-β-producing regulatory T cells from CD4+ CD25− precursors

Vitamin D and chronic diseases

TGF-β requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+ CD25+ regulatory cells

Natural and TGF-β–induced Foxp3+ CD4+ CD25+ regulatory T cells are not mirror images of each other

Role of TNF–TNF receptor 2 signal in regulatory T cells and its therapeutic implications

Cutting edge: Foxp3+ CD4+ CD25+ regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6

Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms

The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3

The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets

Conclusion

Given his outstanding scientific productivity, leadership in global immunology communities, and groundbreaking research on immune regulation, Prof. Song Guo Zheng is highly suitable for the Best Researcher Award. His body of work demonstrates not only scientific depth and innovation but also sustained impact on the field of immunology and clinical medicine. With ongoing contributions and strategic improvements, he remains a central figure in advancing immune-based therapies and education worldwide.